FDA postpones advisory panel meeting on Pfizer Covid-19 vaccine for younger children

The Food and Drug Administration announced Friday that it is postponing the meeting of its Vaccines and Related Biological Products Advisory Committee, originally scheduled for February 15, “as new data has recently emerged” regarding Pfizer and BioNTech’s emergency use authorization request for their Covid-19 vaccine for children younger than 5. Click here to read more.